Chapter
Psychedelics: A New Drug?
1:18:27 - 1:23:09 (04:42)
The risks of psychedelics are minor compared to other drugs.
Clips
The speaker discusses the potential benefits of using psychedelics in treating mental illnesses such as eating disorders and depression, citing their cost effectiveness and favorable risk profile.
1:18:27 - 1:19:24 (00:57)
mental health
Summary
The speaker discusses the potential benefits of using psychedelics in treating mental illnesses such as eating disorders and depression, citing their cost effectiveness and favorable risk profile.
ChapterPsychedelics: A New Drug?
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show
The profile of psilocybin would be very favorable in terms of risks compared to many other drugs, and early indicators suggest it has promising potential, as it can be fatal for some people if mixed incorrectly with medication.
1:19:24 - 1:20:36 (01:11)
Pharmacogenomics
Summary
The profile of psilocybin would be very favorable in terms of risks compared to many other drugs, and early indicators suggest it has promising potential, as it can be fatal for some people if mixed incorrectly with medication.
ChapterPsychedelics: A New Drug?
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show
The risks in this case are minor compared to drugs we take routinely.
1:20:37 - 1:23:09 (02:31)
Business
Summary
The risks in this case are minor compared to drugs we take routinely.